Navigation Links
Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
Date:5/9/2013

, oral tablet for the treatment of opioid-induced constipation.  This agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of naloxegol and an opioid.  NKTR-181, a novel mu-opioid analgesic candidate for chronic pain conditions, is in Phase 2 development in osteoarthritis patients with chronic knee pain.  NKTR-192, a novel mu-opioid analgesic in development to treat acute pain is in Phase 1 clinical development.  In oncology, etirinotecan pegol (NKTR-102) is being evaluated in a Phase 3 clinical study (the BEACON study) for the treatment of metastatic breast cancer and is also in Phase 2 studies for the treatment of ovarian and colorectal cancers. In anti-infectives, Amikacin Inhale is in Phase 3 studies conducted by Bayer Healthcare as an adjunctive treatment for intubated and mechanically ventilated patients with Gram-negative pneumonia.

Nektar's technology has enabled eight approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia.  Additional development-stage products that leverage Nektar's proprietary technology platform include Baxter's BAX 855, a long-acting PEGylated rFVIII program, which is in Phase 3 clinical development.

Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.  Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Cautionary Note Regarding Forward-Looking StatementsThis press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements can be identified by words
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics to Present at the 33rd Annual Cowen and Company Healthcare Conference in Boston
3. Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
4. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
5. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
6. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
8. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
9. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
10. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
11. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 Yesterday, former Congressman Patrick ... manufacturing facility. Rep. Kennedy and Dick Moberg ... cutting-edge research in neurological disease and treatment. ... advocate, Garen Staglin , created One Mind, ... changes that will radically accelerate the development and ...
(Date:7/10/2014)... 2014   LabStyle Innovations Corp . (OTCQB:DRIO), developer ... the appointment of Professor Richard B. Stone ... of Directors. Prof. Stone brings over ... LabStyle as an entrepreneur, venture capitalist public, company ... expert. He currently serves on the board of ...
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients want ... a recent online survey* sponsored by Mission Pharmacal Company. ... National Osteoporosis Foundation online support community, revealed that 74 ... that comes in a form other than a pill ...
Breaking Medicine Technology:Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3
... Expands Enterprise Intelligence Systems to Healthcare Market, ... Booth #1841 --,Harris Corporation (NYSE: HRS ... has joined forces with Cancer Treatment,Services International ... of,radiation oncology. Harris will provide advanced imaging ...
... InteKrin Therapeutics, Inc.,a privately-held clinical stage biopharmaceutical ... novel drugs for the treatment of,diabetes, obesity ... has,initiated a Phase 2b study in diabetic ... non-TZD SPPARM (Selective Peroxisome,Proliferator-Activated Receptor Modulator). INT131 ...
Cached Medicine Technology:Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment 2InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131 2
(Date:7/11/2014)... Ligament (ACL) reconstructions occur more than 200,000 times a ... a new ligament may determine how long you stay ... at the Annual Meeting of the American Orthopaedic Society ... results highlight that in a young athletic population, allografts ... using autografts (tissue harvested from the patient)," said Craig ...
(Date:7/11/2014)... With the maturity and development of ... the installation rate of Chinese car electric window regulators ... exceeded 88% and the demand outnumbered 75 million pieces, ... years, Chinese car electric window regulator market will present ... size is expected to exceed 110 million pieces, with ...
(Date:7/11/2014)... TX (PRWEB) July 11, 2014 Avery ... their customers and to show more about their services ... http://www.kennrenner.com/buyaveryranch/ and view their home videos online, their ... Avery Ranch is Austin, Texas’ premiere golf course community ... city limits of Austin. Avery Ranch features an award ...
(Date:7/11/2014)... the experienced dressmaker in the world, has become one ... to beach wedding dresses . Recently, the firm ... in its online shop. Included in the new range ... has been considered as one of the best garment ... spokesman, BellasDress provides superb special occasion gowns and great ...
(Date:7/11/2014)... Rockville, MD (PRWEB) July 11, 2014 ... Shady Grove Fertility’s Annandale, VA office joined ... Buddy Check 9 to educate the audience about the ... with oncologists to make motherhood possible for ... Grove Fertility and oncologists treat patients in the developing ...
Breaking Medicine News(10 mins):Health News:ACL reconstructions may last longer with autografts 2Health News:China Car Electric Window Regulator Industry to Grow at CAGR of 10% to 2017 Says a New Research Report at ChinaMarketResearchReports.com 2Health News:China Car Electric Window Regulator Industry to Grow at CAGR of 10% to 2017 Says a New Research Report at ChinaMarketResearchReports.com 3Health News:China Car Electric Window Regulator Industry to Grow at CAGR of 10% to 2017 Says a New Research Report at ChinaMarketResearchReports.com 4Health News:Avery Ranch Announces Their New Website to Better Connect with Customers 2Health News:BellasDress Emerges As Popular Online Supplier Of 2014 Beach Wedding Dresses 2Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 2Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 3Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 4
... CHAPEL HILL, N.C. By the age of 20, most people ... recently it was assumed that skeletal enlargement elsewhere in the body ... researchers at the University of North Carolina at Chapel Hill has ... pelvis ("hipbones") does continue to widen as people advance in age ...
... last decade toward a deeper understanding and improved ... that underlie this complex array of conditions and ... On June 2-3, 2011, leading and emerging investigators ... pain and experts in the clinical development of ...
... first time, results on the impact of gaming devices on ... the EULAR 2011 Annual Congress. Data comparing two schools in ... pain following long term use of gaming devices and mobile ... health. , The study, involving 257 students, highlights that a ...
... By Maureen Salamon HealthDay Reporter , TUESDAY, May ... baked or broiled also protects against developing heart failure, a ... women for an average of 10 years found that those ... as five or more servings per week -- had a ...
... 25 (HealthDay News) --,The ability of men and women to ... their romantic relationships can be traced back to their early ... 78 people aged 20 or 21 and their heterosexual partners ... researchers already had data on the participants from when they ...
... tend to have lower earnings and labor force participation ... disability benefits, a new study finds. Rejected applicants ... accepted applicants, according to the research led by economist ... average, the study found, those rejected for benefits made ...
Cached Medicine News:Health News:Pelvic widening continues throughout a person's lifetime, UNC study 2Health News:Investigators explore new frontiers in the development of tomorrow's pain medicines 2Health News:Children experience wrist and finger pain when using gaming devices and mobile phones over time 2Health News:Cooked Right, Fish Can Help a Woman's Heart 2Health News:Cooked Right, Fish Can Help a Woman's Heart 3Health News:Capacity for Commitment May Start in Early Childhood 2Health News:Study finds much different work histories for disability rejects, beneficiaries 2
... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
... a leading provider of immunofluorescence assays, with ... that includes kits for autoimmune diseases, infectious ... conjugates and components. Our Impact IFA Test ... substrates and kit sizes to choose from. ...
Medicine Products: